BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas will participate on a panel titled "Life Sciences Incubation Models" at the International Association of Research Parks World Conference in Raleigh, NC
News | 06. 04. 2009
